4.6 Article

Identification of Essential Genetic Baculoviral Elements for Recombinant Protein Expression by Transactivation in Sf21 Insect Cells

Journal

PLOS ONE
Volume 11, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0149424

Keywords

-

Funding

  1. Helmholtz Protein Sample Production Facility
  2. European Strategy Forum on Research Infrastructures (ESFRI)
  3. European Community's Seventh Framework Programme (FP7) [270089]
  4. President's Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF) [VH-GS-202]

Ask authors/readers for more resources

The Baculovirus Expression Vector System (BEVS) is widely used to produce high amounts of recombinant proteins. Nevertheless, generating recombinant baculovirus in high quality is rather time-consuming and labor-intensive. Alternatively, virus-free expression in insect cells did not achieve similar expression levels for most proteins so far. The transactivation method is a promising approach for protein expression in Sf21 cells. It combines advantages of BEVS and plasmid-based expression by activating strong virus-dependent promoters on a transfected plasmid by baculoviral coinfection. Here, we identified expression elements required for transactivation. Therefore, we designed several vectors comprising different viral promoters or promoter combinations and tested them for eGFP expression using the automated BioLector microcultivation system. Remarkably, only the combination of the very late promoter p10 together with the homologous region 5 (hr5) could boost expression during transactivation. Other elements, like p10 alone or the late viral promoter polH, did not respond to transactivation. A new combination of hr5 and p10 with the strongest immediate early OpMNPV viral promoter OpIE2 improved the yield of eGFP by similar to 25% in comparison to the previous applied hr5-IE1-p10 expression cassette. Furthermore, we observed a strong influence of the transcription termination sequence and vector backbone on the level of expression. Finally, the expression levels for transactivation, BEVS and solely plasmid-based expression were compared for the marker protein eGFP, underlining the potential of transactivation for fast recombinant protein expression in Sf21 cells. In conclusion, essential elements for transactivation could be identified. The optimal elements were applied to generate an improved vector applicable in virus-free plasmid-based expression, transactivation and BEVS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate

Moritz Winterhoff, Fangfang Chen, Nishika Sahini, Thomas Ebensen, Maike Kuhn, Volkhard Kaever, Heike Baehre, Frank Pessler

Summary: Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate, plays a role in innate immunity and metabolism, and has potential as a clinical biomarker. A sensitive HPLC-MS/MS assay was developed to quantify itaconate, mesaconate, citraconate, and selected TCA intermediates. Different levels of itaconate isomers were found in various biological samples, indicating the importance of quantifying them separately in biomarker studies.

METABOLITES (2021)

Article Gastroenterology & Hepatology

Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis

Richard Taubert, Bastian Engel, Jana Diestelhorst, Katharina L. Hupa-Breier, Patrick Behrendt, Niklas T. Baerlecken, Kurt-Wolfram Suehs, Maciej K. Janik, Kalliopi Zachou, Marcial Sebode, Christoph Schramm, Maria-Carlota Londono, Sarah Habes, Ye H. Oo, Claudine Lalanne, Simon Pape, Maren Schubert, Michael Hust, Stefan Duebel, Mario Thevis, Danny Jonigk, Julia Beimdiek, Falk F. R. Buettner, Joost P. H. Drenth, Luigi Muratori, David H. Adams, Jessica K. Dyson, Amedee Renand, Isabel Graupera, Ansgar W. Lohse, George N. Dalekos, Piotr Milkiewicz, Martin Stangel, Benjamin Maasoumy, Torsten Witte, Heiner Wedemeyer, Michael P. Manns, Elmar Jaeckel

Summary: This study identified more accurate autoantibodies for diagnosing autoimmune hepatitis (AIH) using a protein macroarray, which showed higher specificity and sensitivity compared to conventional autoantibodies. These antibodies could be used as promising markers to improve the diagnostic workup of liver diseases, particularly in cases of seronegative AIH.

HEPATOLOGY (2022)

Review Immunology

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, Stephan Steinke, Nora Langreder, Philip Alexander Heine, Kai-Thomas Schneider, Rico Ballmann, Viola Fuehner, Philipp Kuhn, Thomas Schirrmann, Andre Frenzel, Stefan Duebel, Maren Schubert, Gustavo Marcal Schmidt Garcia Moreira, Federico Bertoglio, Giulio Russo, Michael Hust

Summary: Antibodies are crucial for the diagnosis and treatment of diseases caused by pathogens. Their importance has been highlighted during the COVID-19 pandemic, and new technologies like antibody phage display have advanced the discovery of human monoclonal antibodies for therapeutic purposes. These technologies have expanded the possibilities for generating antibodies against a wide range of pathogens and toxins.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Biology

Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Sergej Franz, Fabian Pott, Thomas Zillinger, Christiane Schueler, Sandra Dapa, Carlo Fischer, Vania Passos, Saskia Stenzel, Fangfang Chen, Katinka Doehner, Gunther Hartmann, Beate Sodeik, Frank Pessler, Graham Simmons, Jan Felix Drexler, Christine Goffinet

Summary: IFITM proteins restrict entry and spread of chikungunya virus and Mayaro virus, with CHIKV showing antagonism against IFITMs. CHIKV infection may lead to posttranscriptional regulation of IFITM3, resulting in reduced antiviral activity.

LIFE SCIENCE ALLIANCE (2021)

Article Virology

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins

Marina Pribanic Matesic, Paola Kucan Brlic, Tihana Lenac Rovis, Zeljka Macak Safranko, Abigael Eva Chaouat, Karmela Miklic, Suzana Malic, Nina Ivankovic, Maren Schubert, Federico Bertoglio, Alemka Markotic, Ofer Mandelboim, Stipan Jonjic, Ilija Brizic

Summary: This article presents the development and characterization of a collection of new monoclonal antibodies targeting different SARS-CoV-2 proteins. These antibodies can be applied in various experimental methods such as flow cytometry, immunofluorescence, and Western blot, providing new tools for a comprehensive analysis of the viral proteome.

VIRUSES-BASEL (2022)

Article Biochemistry & Molecular Biology

Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein

Marc Sevenich, Elena Thul, Nils-Alexander Lakomek, Thomas Kluenemann, Maren Schubert, Federico Bertoglio, Joop van den Heuvel, Patrick Petzsch, Jeannine Mohrlueder, Dieter Willbold

Summary: The emergence of novel variants of concern poses a challenge to the immune system, highlighting the need for tailored antiviral medications for patients with incomplete or inefficient immunization.

BIOMEDICINES (2022)

Article Medicine, General & Internal

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Henrike Maass, Jose Camilla Sammartino, Irene Cassaniti, Fanglei Zuo, Likun Du, Janin Korn, Marko Milosevic, Esther Veronika Wenzel, Fran Krstanovic, Saskia Polten, Marina Pribanic-Matesic, Ilija Brizic, Fausto Baldanti, Lennart Hammarstrom, Stefan Duebel, Alan Sustic, Harold Marcotte, Monika Strengert, Alen Protic, Antonio Piralla, Qiang Pan-Hammarstroem, Luka Cicin-Sain, Michael Hust

Summary: This study analyzed the binding ability of the Omicron variant to the human receptor and its neutralization efficacy. The results showed weaker binding and complete loss of neutralization against Omicron compared to previous variants. However, booster vaccination increased the antibody levels and partially restored neutralization against Omicron SARS-CoV-2.

BMC MEDICINE (2022)

Article Virology

ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Rico Ballmann, Sven-Kevin Hotop, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, M. Zeeshan Chaudhry, Dieter Jahn, Boas Pucker, Fausto Baldanti, Antonio Piralla, Maren Schubert, Luka Cicin-Sain, Mark Broenstrup, Michael Hust, Stefan Duebel

Summary: The development of antibody therapies against SARS-CoV-2 is challenging due to the mutations in the receptor binding domain (RBD) of the spike. In this study, a phage display library was constructed to identify immunogenic epitopes from COVID-19 patients. The most prominent epitope captured was a part of the fusion peptide (FP) of the spike, which is associated with the virus entry mechanism. Blocking this mechanism could be a potential target for therapeutic antibodies.

VIRUSES-BASEL (2022)

Article Biochemistry & Molecular Biology

Itaconate Isomers in Bread

Mona Gruenwald, Fangfang Chen, Heike Baehre, Frank Pessler

Summary: Itaconate isomers, including itaconate, mesaconate, and citraconate, were detected in low concentrations in bread. The concentrations of itaconate and citraconate were higher in the crust than in the crumb of wheat and rye bread, while a slight increase in mesaconate was observed in the crust of rye bread. Cis-aconitate concentrations were lower in the crust, suggesting conversion to itaconate isomers during baking. The estimated daily intake of itaconate isomers from baked goods is roughly 7-20 μg.

ANTIOXIDANTS (2022)

Article Virology

Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment

Marcel Jaron, Michael Lehky, Marta Zara, Chris Nicole Zaydowicz, Aidin Lak, Rico Ballmann, Philip Alexander Heine, Esther Veronika Wenzel, Kai-Thomas Schneider, Federico Bertoglio, Susanne Kempter, Reinhard Wolfgang Koester, Silvia Stella Barbieri, Joop van den Heuvel, Michael Hust, Stefan Duebel, Maren Schubert

Summary: This study presents a fast and powerful method for producing SARS-CoV-2 VLPs in insect cells and evaluating their ability to inhibit monoclonal antibodies and sera from vaccinated donors. The method involves direct plasmid transfection to co-express specific viral proteins, resulting in the self-assembly of VLPs. The VLPs obtained were confirmed to have a diameter of approximately 145 nm and exhibited characteristic features by nanoparticle tracking analysis and transmission electron microscopy. The fusion of membrane protein with GFP allowed for quantification of binding inhibition to ACE2 without the need for purification or labeling.

VIRUSES-BASEL (2022)

Article Virology

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study

Paola Kucan Brlic, Martina Pavletic, Mate Lerga, Fran Krstanovic, Marina Pribanic Matesic, Karmela Miklic, Suzana Malic, Leonarda Miksa, Maja Pajcur, Dolores Peruc, Maren Schubert, Federico Bertoglio, Jurica Arapovic, Alen Protic, Alan Sustic, Marko Milosevic, Luka Cicin Sain, Stipan Jonjic, Vanda Juranic Lisnic, Ilija Brizic

Summary: This study assessed the dynamics of antibody responses to SARS-CoV-2 infection and vaccination, finding sustained anti-Spike antibody responses in vaccinated health-care workers (HCW), but a waning anti-Nucleocapsid response over a six-month period. Additionally, a significant decrease in vaccinees' anti-Spike antibody binding to the Spike protein of the Omicron variant was observed. Critically ill COVID-19 patients had higher levels of anti-Spike and anti-Nucleocapsid antibodies compared to HCWs, and a stronger anti-Spike antibody response correlated with a better disease outcome in patients on invasive ventilation support.

VIRUSES-BASEL (2022)

Review Biochemistry & Molecular Biology

Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5

Fangfang Chen, Hanna Friederike Willenbockel, Thekla Cordes

Summary: Citrate, a small molecule, plays a crucial role in cell metabolism and function. It is taken up by cells through the NaCT transporter and is essential for maintaining metabolic homeostasis. Impaired NaCT activity is associated with metabolic disorders.

METABOLITES (2023)

Letter Health Care Sciences & Services

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1

Fanglei Zuo, Rui Sun, Hassan Abolhassani, Likun Du, Yating Wang, Stelios Vlachiotis, Federico Bertoglio, Maren Schubert, Nima Rezaei, Zahra Chavoshzadeh, Concetta Guerra, Andrea Cavalli, Juni Andrell, Makiko Kumagai-Braesch, Yintong Xue, Yunlong Cao, Michael Hust, Davide F. Robbiani, Xiaoliang Sunney Xie, Lennart Hammarstrom, Harold Marcotte, Qiang Pan-Hammarstrom

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Article Virology

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns

Leila Abassi, Federico Bertoglio, Zeljka Macak Safranko, Thomas Schirrmann, Marina Greweling-Pils, Oliver Seifert, Fawad Khan, Maeva Katzmarzyk, Henning Jacobsen, Natascha Goedecke, Philip Alexander Heine, Andre Frenzel, Helena Nowack, Stefan Duebel, Ivan-Christian Kurolt, Roland E. Kontermann, Alemka Markotic, Maren Schubert, Michael Hust, Luka Cicin-Sain

Summary: The COVID-19 pandemic has resulted in a large number of confirmed cases and deaths. The use of vaccines and monoclonal antibodies has been limited by the emergence of new variants. This study investigates the neutralizing effects of monoclonal antibody STE90-C11 against the Delta and Omicron variants and finds that Omicron evades recognition by this antibody.

VIRUSES-BASEL (2023)

Article Medicine, Research & Experimental

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection

Natalia Sherina, Antonio Piralla, Likun Du, Hui Wan, Makiko Kumagai-Braesch, Juni Andrell, Sten Braesch-Andersen, Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Federica Bergami, Raffaella Di Martino, Marta Colaneri, Marco Vecchia, Margherita Sambo, Valentina Zuccaro, Raffaele Bruno, Michele Sachs, Tiberio Oggionni, Federica Meloni, Hassan Abolhassani, Federico Bertoglio, Maren Schubert, Miranda Byrne-Steele, Jian Han, Michael Hust, Yintong Xue, Lennart Hammarstrom, Fausto Baldanti, Harold Marcotte, Qiang Pan-Hammarstrom

Summary: The study shows that 85% of samples from COVID-19 patients had anti-SARS-CoV-2 antibodies within 4 weeks of symptom onset, while specific IgG antibodies and plasma neutralizing activities remained relatively stable up to 6 months after diagnosis. 80% of samples collected at 6-8 months after symptom onset still had anti-SARS-CoV-2 IgG antibodies, and specific memory B and T cell responses continued to develop and persist.
No Data Available